Abstract
This study compared lipids, the product of lipid peroxidation malondialdehyde (MDA), the acute phase reactant high sensitive C-reactive protein (hsCRP), endothelin-1 (ET-1),
This study compared lipids, the product of lipid peroxidation malondialdehyde (MDA), the acute phase reactant high sensitive C-reactive protein (hsCRP), endothelin-1 (ET-1),
O. I. Stenina, “Regulation of vascular genes by glucose,” Current Pharmaceutical Design, vol. 11, no. 18, pp. 2367–2381, 2005.
View at: Publisher Site | Google ScholarR. C. A. Tostes and M. N. Muscará, “Endothelin receptor antagonists: another potential alternative for cardiovascular diseases,” Current Drug Targets - Cardiovascular and Haematological Disorders, vol. 5, no. 4, pp. 287–301, 2005.
View at: Publisher Site | Google ScholarP. A. Insel, S. Kornfeld, P. W. Majerus et al., “Blasts from the past,” Journal of Clinical Investigation, vol. 114, no. 8, pp. 1017–1033, 2004.
View at: Publisher Site | Google ScholarM. Meydani, “Soluble adhesion molecules: surrogate markers of cardiovascular disease?” Nutrition Reviews, vol. 61, no. 2, pp. 63–68, 2003.
View at: Publisher Site | Google ScholarG. Davì, A. Falco, and C. Patrono, “Lipid peroxidation in diabetes mellitus,” Antioxidants and Redox Signaling, vol. 7, no. 1-2, pp. 256–268, 2005.
View at: Publisher Site | Google ScholarA. Ergul, J. S. Johansen, C. Strømhaug et al., “Vascular dysfunction of venous bypass conduits is mediated by reactive oxygen species in diabetes: role of endothelin-1,” Journal of Pharmacology and Experimental Therapeutics, vol. 313, no. 1, pp. 70–77, 2005.
View at: Publisher Site | Google ScholarE. C. Abraham, T. A. Huff, N. D. Cope, J. B. Wilson Jr., E. D. Bransome Jr., and T. H. Huisman, “Determination of the glycosylated hemoglobins (Hb ) with a new microcolumn procedure. Suitability of the technique for assessing the clinical management of diabetes mellitus,” Diabetes, vol. 27, no. 9, pp. 931–937, 1978.
View at: Google ScholarP. Trinder, “Determination of blood glucose using an oxidase-peroxidase system with a non-carcinogenic chromogen,” Journal of Clinical Pathology, vol. 22, no. 2, pp. 158–161, 1969.
View at: Google ScholarW. Richmond, “Preparation and properties of a cholesterol oxidase from Nocardia sp. and its application to the enzymatic assay of total cholesterol in serum,” Clinical Chemistry, vol. 19, no. 12, pp. 1350–1356, 1973.
View at: Google ScholarJ. Siedel, E. O. Hagele, J. Ziegenhorn, and A. W. Wahlefeld, “Reagent for the enzymatic determination of serum total cholesterol with improved lipolytic efficiency,” Clinical Chemistry, vol. 29, no. 6, pp. 1075–1080, 1983.
View at: Google ScholarM. Burstein, H. R. Scholnick, and R. Morfin, “Rapid method for the isolation of lipoproteins from human serum by precipitation with polyanions,” Journal of Lipid Research, vol. 11, no. 6, pp. 583–595, 1970.
View at: Google ScholarW. T. Friedewald, R. I. Levy, and D. S. Fredrickson, “Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge,” Clinical Chemistry, vol. 18, no. 6, pp. 499–502, 1972.
View at: Google ScholarJ. I. Cleeman, “Executive summary of the third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment panel III),” Journal of the American Medical Association, vol. 285, no. 19, pp. 2486–2497, 2001.
View at: Publisher Site | Google ScholarD. R. Janero, “Malondialdehyde and thiobarbituric acid-reactivity as diagnostic indices of lipid peroxidation and peroxidative tissue injury,” Free Radical Biology and Medicine, vol. 9, no. 6, pp. 515–540, 1990.
View at: Publisher Site | Google ScholarD. G. Waller, A. G. Renwick, and K. Hillier, “Ischaemic heart disease,” in Medical Pharmacology and Therapeutics, p. 81, W. B. Saunders, Philadelphia, Pa, USA, 2001, chapter 5.
View at: Google ScholarC. Vitale, M. Fini, F. Leonardo et al., “Effect of estradiol valerate alone or in association with cyproterone acetate upon vascular function of postmenopausal women at increased risk for cardiovascular disease,” Maturitas, vol. 40, no. 3, pp. 239–245, 2001.
View at: Publisher Site | Google ScholarK. Matsumoto, Y. Sera, Y. Abe et al., “High serum concentrations of soluble E-selectin correlate with obesity but not fat distribution in patients with type 2 diabetes mellitus,” Metabolism, vol. 51, no. 7, pp. 932–934, 2002.
View at: Publisher Site | Google ScholarN. Kaul, S. Devaraj, and I. Jialal, “-tocopherol and atherosclerosis,” Proceedings of the Society for Experimental Biology and Medicine, vol. 226, no. 1, pp. 5–12, 2001.
View at: Google ScholarF. O. Pereira, T. S. Frode, and Y. S. Medeiros, “Evaluation of tumour necrosis factor alpha, interleukin-2 soluble receptor, nitric oxide metabolites, and lipids as inflammatory markers in type 2 diabetes mellitus,” Mediators of Inflammation, vol. 2006, Article ID 39062, p. 7, 2006.
View at: Publisher Site | Google ScholarM. B. Schulze, E. B. Rimm, T. Li, N. Rifai, M. J. Stampfer, and F. B. Hu, “C-reactive protein and incident cardiovascular events among men with diabetes,” Diabetes Care, vol. 27, no. 4, pp. 889–894, 2004.
View at: Google ScholarA. Saitta, D. Altavilla, D. Cucinotta et al., “Randomized, double-blind, placebo-controlled study on effects of raloxifene and hormone replacement therapy on plasma NO concentrations, endothelin-1 levels, and endothelium-dependent vasodilation in postmenopausal women,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 21, no. 9, pp. 1512–1519, 2001.
View at: Google ScholarE. Ercan, H. Bozdemir, I. Tengiz et al., “Decreased soluble cell adhesion molecules after tirofiban infusion in patients with unstable angina pectoris,” Thrombosis Journal, vol. 2, no. 1, pp. 4–9, 2004.
View at: Publisher Site | Google ScholarL. Calabresi, M. Gomaraschi, B. Villa, L. Omoboni, C. Dmitrieff, and G. Franceschini, “Atherosclerosis and Lipoproteins: elevated soluble cellular adhesion molecules in subjects with low HDL-cholesterol,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 22, no. 4, pp. 656–661, 2002.
View at: Publisher Site | Google ScholarT. Kerner, O. Ahlers, H. Reschreiter, C. Bührer, M. Möckel, and H. Gerlach, “Adhesion molecules in different treatments of acute myocardial infarction,” Critical Care, vol. 5, no. 3, pp. 145–150, 2001.
View at: Publisher Site | Google ScholarN. Zimmermann, A. Wenk, U. Kim et al., “Functional and biochemical evaluation of platelet aspirin resistance after coronary artery bypass surgery,” Circulation, vol. 108, no. 5, pp. 542–547, 2003.
View at: Publisher Site | Google ScholarI. Kowalska, M. Straczkowski, M. Szelachowska et al., “Circulating E-selectin, vascular cell adhesion molecule-1, and intercellular adhesion molecule-1 in men with coronary artery disease assessed by angiography and disturbances of carbohydrate metabolism,” Metabolism, vol. 51, no. 6, pp. 733–736, 2002.
View at: Publisher Site | Google Scholar